Compare OTIS & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTIS | NTRA |
|---|---|---|
| Founded | 1853 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5B | 28.0B |
| IPO Year | 2019 | 2015 |
| Metric | OTIS | NTRA |
|---|---|---|
| Price | $77.98 | $199.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 15 |
| Target Price | $99.63 | ★ $259.07 |
| AVG Volume (30 Days) | ★ 3.0M | 1.2M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | N/A | ★ 0.65 |
| EPS | ★ 0.87 | N/A |
| Revenue | N/A | ★ $210,939,000.00 |
| Revenue This Year | $6.94 | $18.08 |
| Revenue Next Year | $4.83 | $19.65 |
| P/E Ratio | $89.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $75.27 | $131.81 |
| 52 Week High | $101.42 | $256.36 |
| Indicator | OTIS | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 47.46 |
| Support Level | $75.27 | $186.89 |
| Resistance Level | $92.98 | $204.34 |
| Average True Range (ATR) | 1.90 | 9.67 |
| MACD | 0.01 | -0.21 |
| Stochastic Oscillator | 27.07 | 44.55 |
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.